SAG
SageView Advisory Group’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46M | Buy |
11,711
+539
| +5% | +$436K | 0.36% | 31 |
|
|
2025
Q1 | $9.23M | Sell |
11,172
-60
| -0.5% | -$49.6K | 0.39% | 31 |
|
|
2024
Q4 | $8.67M | Buy |
11,232
+230
| +2% | +$178K | 0.37% | 35 |
|
|
2024
Q3 | $9.75M | Sell |
11,002
-2,283
| -17% | -$2.02M | 0.49% | 27 |
|
|
2024
Q2 | $12M | Buy |
13,285
+1,919
| +17% | +$1.74M | 0.56% | 26 |
|
|
2024
Q1 | $8.84M | Sell |
11,366
-1,646
| -13% | -$1.28M | 0.45% | 32 |
|
|
2023
Q4 | $8.39M | Buy |
13,012
+3,568
| +38% | +$2.3M | 0.36% | 35 |
|
|
2023
Q3 | $5.07M | Buy |
9,444
+67
| +0.7% | +$36K | 0.29% | 45 |
|
|
2023
Q2 | $4.4M | Buy |
9,377
+1,107
| +13% | +$519K | 0.24% | 58 |
|
|
2023
Q1 | $2.84M | Buy |
8,270
+303
| +4% | +$104K | 0.18% | 88 |
|
|
2022
Q4 | $2.91M | Buy |
+7,967
| New | +$2.91M | 0.24% | 74 |
|